Keros Therapeutics, Inc. (KROS)
Pharmaceutical Preparations · Healthcare · $198M
Intrinsic Value (Consensus)
$31.37
Current Price
$10.03
Margin of Safety
+212.8%
212.8% Below Intrinsic Value
Value: $31
Price: $10
Valuation Model Estimates
Current Price: $10.03
DCF (Discounted Cash Flow)
$28.95
Graham Number
$28.20
Earnings Power Value
$22.33
Relative Value (P/E)
$46.00
Dividend Discount Model
Not applicable
—
Consensus Value
$31.37
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
80
Profitability
25/25
Strength
17/25
Valuation
22/25
Growth
16/25
Financial Health Signals
Strong profitability — ROE of 29% (above 20% is excellent)
High free cash flow yield (53.5%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $2.30
- EPS (Forward)
- $2.42
- Book Value
- $15.36
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 28.7%
- Debt/Equity
- —
- Revenue Growth
- 6775.0%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance